The Diels-Alder reaction is one of the most well-studied, synthetically useful organic transformations. Although it has been postulated that a significant number of naturally occurring substances arise by biosynthetic Diels-Alder reactions, rigorous confirmation of a mechanistically distinct natural Diels-Alderase enzyme remains elusive. Within this context, several related fungi within the Aspergillus genus produce a number of metabolites of opposite absolute configuration, including (1)-or (2)-versicolamide B. These alkaloids are hypothesized to arise via biosynthetic Diels-Alder reactions, implying that each Aspergillus species possesses enantiomerically distinct Diels-Alderases. In this paper, experimental validation of these biosynthetic proposals via deployment of the intramolecular hetero-Diels-Alder reaction as a key step in the asymmetric total syntheses of (1)-and (2)-versicolamide B is described. Laboratory validation of the proposed biosynthetic DielsAlder construction, coupled with the secondary metabolite profile of the producing fungi, reveals that each Aspergillus species has evolved enantiomerically distinct indole oxidases, as well as enantiomerically distinct Diels-Alderases.
The Diels-Alder reaction is one of the most well-studied, synthetically useful organic transformations. Although it has been postulated that a significant number of naturally occurring substances arise by biosynthetic Diels-Alder reactions, rigorous confirmation of a mechanistically distinct natural Diels-Alderase enzyme remains elusive. Within this context, several related fungi within the Aspergillus genus produce a number of metabolites of opposite absolute configuration, including (1)-or (2)-versicolamide B. These alkaloids are hypothesized to arise via biosynthetic Diels-Alder reactions, implying that each Aspergillus species possesses enantiomerically distinct Diels-Alderases. In this paper, experimental validation of these biosynthetic proposals via deployment of the intramolecular hetero-Diels-Alder reaction as a key step in the asymmetric total syntheses of (1)-and (2)-versicolamide B is described. Laboratory validation of the proposed biosynthetic DielsAlder construction, coupled with the secondary metabolite profile of the producing fungi, reveals that each Aspergillus species has evolved enantiomerically distinct indole oxidases, as well as enantiomerically distinct Diels-Alderases.
A seemingly limitless array of natural secondary metabolites are produced in nature from plants, microorganisms and animals in both terrestrial and marine environments. In the overwhelming majority of cases, these secondary metabolites, commonly referred to as 'natural products', are produced in optically pure form (when chiral). In the plant kingdom, examples of different species producing enantiomerically opposite metabolites are well documented but rare. Some of the most well-known examples are terpenes, such as carvone, camphor and limonene. These substances arise from an initial enzyme-catalysed cyclization of geranyl pyrophosphate, and the observation of antipodal terpenes in nature has been attributed to species-or genus-specific enantiodivergent cyclases, which cyclize geranyl pyrophosphate to give opposite enantiomers of limonene or borneol 1 . These are further metabolized to give other enantiomerically distinct terpenes.
Although they are much rarer, different genera of marine sponge have also been reported to produce antipodal, manzamine alkaloids, with an Iricina species producing ircinal A and B and an Amphimedon species producing the antipodal congeners iricinol A and B (ref. 2). This example is particularly notable in that an intramolecular Diels-Alder reaction from an achiral substrate has been invoked in the proposed biosynthesis of these manzamine alkaloids 3 . The above examples reveal that antipodal natural products often result from the action of stereochemically distinct enzymes that can give single and opposite enantiomeric products from achiral substrates.
The diverse family of prenylated indole alkaloids containing a bicyclo[2.2.2]diazaoctane core isolated from both terrestrial and marine fungi have been the subject of intense research efforts owing to their complex molecular structures and range of biological activities 4, 5 (Fig. 1) . Members of this family of prenylated indole alkaloids have been reported to display insecticidal, antitumor, antihelmintic, calmodulin-inhibitory and antibacterial properties [6] [7] [8] .
Work from our laboratory 4 , as well as that from Sammes 9 and Birch 10 , has revealed that these alkaloids are all derived from one or two mevalonate-derived isoprene units, tryptophan, and a cyclic amino acid such as proline, b-methylproline or pipecolic acid. Significant experimental evidence suggests that the bicyclo[2.2.2]diazaoctane core common to all of these natural products arises biosynthetically via an intramolecular heteroDiels-Alder (IMDA) reaction of a 5-hydroxypyrazin-2(1H)-one 4, 9 . Indeed, we have applied such IMDA cycloaddition strategies to the total synthesis of several of these prenylated indole alkaloids, Within the family of prenylated alkaloids containing a bicyclo[2.2.2]diazaoctane core, two distinct stereochemistries have been noted with respect to the relative configuration at the C19 stereogenic centre (sclerotiamide numbering, Fig. 1 ). Whereas the brevianamides 9 and 10 possess an anti relative configuration, all of the members of the paraherquamide and notoamide family, such as 1, 2, 5, 6 and 7, possess a syn relative configuration. To date, all of the stephacidins isolated also possess a syn configuration (C6, stephacidin numbering), except for one notable exception, versicolamide B (8; ref. 20) . Owing in part to this stereochemical anomaly, versicolamide B (8) attracted our interest from both a biogenetic and a synthetic perspective.
As mentined above, it has been hypothesized that the bicyclo[2.2.2]diazaoctane core common to all of these natural products arises biosynthetically via an IMDA reaction, and evidence is mounting that this key transformation is most likely enzymemediated. Enzyme-catalysed Diels-Alder reactions have been proposed in the biosynthesis of a large number of natural products 21 ; however, rigorous proof that a mechanistically distinct enzyme can indeed catalyse this pericyclic cycloaddition reaction through the requisite concerted transition state is still lacking. With that in mind, a persuasive body of work has accumulated that indirectly supports the existence of these elusive Diels-Alderase enzymes, and biomimetic total syntheses of various natural products have had a major role in providing this evidence. For example, Baldwin and Whitehead initially proposed that the manzamine alkaloids arise by an intramolecular Diels-Alder cycloaddition of an achiral bispyridinium macrocyclic species 3 . Subsequent isolation of these bispyridinium alkaloids from the producing organism provided support for this biosynthetic proposal 22 , and elegant synthetic work further confirmed that these alkaloids do indeed undergo Diels-Alder reaction in the laboratory to provide keramaphidin B (ref. 23 ), a precursor to the manzamide alkaloids, albeit in very low yield. Although their synthesis produced racemic keramaphidin B, the fact that this and other manzamine alkaloids are isolated as In addition to the diverse biological activity exhibited by these natural products, their structural diversity is also notable. Despite this structural diversity, all of these compounds share a bicyclo[2.2.2]diazaoctane core, which is thought to arise biosynthetically through a hetero-Diels-Alder reaction. Two distinct stereochemistries have been observed with respect to the relative configuration at the C19 stereogenic centre (sclerotiamide numbering), either an anti configuration (for example 9 and 10) or a syn configuration (for example 1 and 2). Versicolamide B is the only member of the stephacidin family to possess an anti configuration.
One pathway is oxidation of notoamide E (11) to the corresponding azadiene 12, followed by IMDA and indole oxidation (top pathway). Alternatively, indole oxidation could occur first to give the oxindole 14, followed by a subsequent oxidation to provide the azadiene 15 and IMDA (bottom pathway).
single enantiomers suggests that the putative biosynthetic Diels-Alder reaction takes place in the chiral environment of an enzyme. Ichihara and co-workers provided particularly compelling evidence of a possible enzyme-catalysed Diels-Alder reaction in nature by studying the biosynthesis of the solanapyrones 24 . By carrying out feeding studies, they observed incorporation of isotopically labelled, achiral Diels-Alder precursors into solanapyrone A, and they also showed that the isotopically labelled solanapyrone A was enantiomerically enriched, thus convincingly eliminating the possibility of a spontaneous cycloaddition. It should also be noted that alternative, stepwise (non-concerted) pathways can be invoked to rationalize the construction of molecular skeletons that otherwise seem to be Diels-Alder constructions 25 . As the number of secondary metabolites that can be rationalized as arising from a key, biosynthetic Diels-Alder reaction accumulates, especially in cases where the candidate achiral Diels-Alder substrates lead to enantiomerically pure products, the case for the existence of Diels-Alderase enzymes in nature has become increasingly compelling.
From a biogenetic perspective, we envisioned that versicolamide B could plausibly arise via two distinct pathways, as illustrated in Fig. 2 . Oxidation of notoamide E (11) could lead to the azadiene 12, which undergoes an IMDA cycloaddition directly providing stephacidin A (3) and C6-epi-stephacidin A (13) . From compound 13, oxidation of the indole and subsequent pinacol rearrangement would give rise to versicolamide B. Notably, we have demonstrated that the laboratory oxidation and pinacol rearrangement of C6-epistephacidin A (13) does indeed provide versicolamide B (8) , and identical reaction conditions provide notoamide B (6) from stephacidin A. However, further complicating this biogenetic proposal was the recent and provocative discovery that the (2)-stephacidin A ( (2) To date, C6-epi-stephacidin A (13) has yet to be detected as a natural metabolite from Aspergillus species, and that has raised questions concerning the validity of this chemically feasible pathway with respect to the biogenesis of versicolamide B (8).
Here, we wish to suggest an alternative pathway wherein oxidation and pinacol rearrangement of notoamide E (11) might occur first, furnishing the oxindole C3-epi-notoamide C (14) , which has recently been detected by Tsukamoto and co-workers as a natural metabolite of the marine-derived Aspergillus species. Subsequent oxidation of 14 could provide the azadiene 15, which, on Diels-Alder reaction, would provide 8. Ab initio calculations 26, 27 , as well as previous synthetic studies, suggest that the oxindole DielsAlder substrate 15 would undergo cycloaddition to provide the anti stereochemistry at C19 in a highly selective, if not exclusive, fashion. Notably, the Diels-Alder reaction of 12 takes place via an achiral azadiene, raising questions concerning the mechanism by which the paraherquamides, notoamides and stephacidins are biosynthesized in enantiomerically pure form 20 . We have endeavoured to secure experimental support to validate these biogenetic hypotheses, and the corroborating enantioselective total syntheses of (þ)-and (2)-versicolamide B (8) are reported herein.
The discovery of distinct Aspergillus species that produce at least three secondary metabolites with the opposite absolute configurations is striking and demands both a genetic and a mechanistic explanation. The possibility that individual species of the Aspergillus genus have evolved enantiomerically distinct genes that direct the biosynthesis of either (þ)-or (2)-versicolamide B as well as the corresponding enantiomeric pairs of stephacidin A and notoamide B was unexpected and, to us, fascinating. We have endeavoured to accumulate experimental support for the biosynthetic hypotheses illustrated in Fig. 2 by undertaking biomimetic total syntheses of (þ)-and (2)-versicolamide B through the putative azadiene 15 that would, at the molecular level, validate the postulated pathways.
Results
The syntheses began with the known protected amino acid 16, which has been used as a synthetic intermediate for the total syntheses of notoamides B, C and D and of stephacidin A (Fig. 3) 12 .
Coupling of 16 with (R)-cis-3-hydroxy-L-proline (17) gave the amide 18 as a 1 : 1 mixture of diastereomers, which underwent fluorenylmethyloxycarbonyl (Fmoc) deprotection on treatment with diethylamine, and concomitant cyclization to provide the readily separable dioxopiperazines 19 and 20.
With the substrates 19 and 20 in hand, we next directed our attention to oxidation of the indole C2-C3 double bond and Diels-Alder cycloaddition to complete the synthesis (Fig. 4) . Treatment of the cis-dioxopiperazine 19 with the oxaziridine reagent 21 resulted in oxidation of the indole C2-C3 double bond followed by pinacol rearrangement to afford the oxindoles 22 and (Fig. 5) . As predicted by ab initio calculations 26, 27 , only the anti cycloadducts were isolated from the hetero-Diels-Alder reactions of the oxindolic azadienes 15 and 31, and no syn cycloadducts were detected. The exclusive preference for the anti cycloadducts is particularly striking, considering that all previous cycloadditions using indole-based azadienes, such as 12, had modest syn selectivity (typically about 2.5 : 1 syn : anti). The current work complements previous experimental support 29, 30 for the theoretical calculations of Domingo and co-workers, who investigated the slightly simpler model system 32 (Fig. 6) . These calculations predicted a 4-7 kcal mol 21 preference for the formation of the anti cycloadduct 33. The absolute configurations of the cycloadducts were confirmed by CD spectroscopy and comparison with that of natural (þ)-versicolamide B ((þ)-8). Working backwards, we could corroborate the absolute configurations of all of the oxindole intermediates 22-29.
Discussion
Confirmation by experiment that the Diels-Alder reaction of 23 or 27 yields (þ)-versicolamide B ((þ)-8) leads to a number of intriguing biosynthetic possibilities, which could help to explain an unresolved stereochemical paradox with regard to the biosynthetic relationships between (þ)-versicolamide B ((þ)-8), (2)-stephacidin A ((2)-3) and (þ)-notoamide B ((þ)-6). Previous work from our laboratory revealed that the fungus Aspergillus versicolor NRRL 35600, from which (þ)-versicolamide B ((þ)-8) was isolated, produces the opposite enantiomers of stephacidin A (3) and notoamide B (6) 7) and from the marine-derived Aspergillus species, studied by Tsukamoto and co-workers 31 . As mentioned above (see Fig. 2 ), versicolamide B ((þ)-8) can arise biogenetically from oxidation and pinacol rearrangement of C6-epi-stephacidin A (13) or from Diels-Alder reaction of the oxindolic azadiene 15. The observation that (þ)-versicolamide B ((þ)-8) is pseudoenantiomeric to both (2)-stephacidin A ((2)-3) and (þ)-notoamide B ((þ)-6), all of which are isolated from the same organism, suggests that (þ)-versicolamide B ((þ)-8) might plausibly arise from the latter pathway involving IMDA reaction of the oxindolic azadiene 15 derived from the natural metabolite C3-epi-notoamide C (14) . If such a pathway is operative, we anticipate that perhaps the versicolamide diastereomer (þ)-30 is an as-yet undetected minor metabolite, and efforts to identify this compound are underway. Alternatively, perhaps each species of Aspergillus possesses a distinct and enantiomerically opposite Diels-Alderase enzyme that pre-organizes the azadiene substrates such that only one enantiomeric cycloadduct is produced.
In conclusion, the first asymmetric total synthesis of each enantiomer of versicolamide B (8) has been achieved. This work provides the first experimental support for the biogenetic hypothesis that versicolamide B (8) possibly arises from IMDA reaction of an oxindolic substrate such as 15. The preference for exclusive formation of the anti cycloadducts in this work stands in stark contrast to the modest syn selectivity exhibited by all of the previous examples of hetero-Diels-Alder reactions on indole-based azadienes [4] [5] [6] [7] [8] . The total synthesis recorded herein will enable the preparation of a number of 13 C-labelled biosynthetic intermediates that will be useful for biosynthetic precursor incorporation experiments that are planned. That work is the subject of current investigation, and will be reported in due course.
Methods

1
H-and 13 C-NMR spectra were obtained using 300 or 400 MHz spectrometers. The chemical shifts are given in parts per million (ppm) relative to tetramethylsilane at d 0.00 ppm or CDCl 3 at d 7.27 ppm for proton spectra and relative to CDCl 3 at d 77.23 ppm for carbon spectra. Infrared spectra were recorded on a Fourier-transform infrared (FTIR) spectrometer as thin films. Mass spectra were obtained using a high/low-resolution magnetic sector mass spectrometer. Flash column chromatography was performed with silica gel grade 60 (230-400 mesh). Unless otherwise noted, materials were obtained from commercially available sources and used without further purification. Dichloromethane (CH 2 Cl 2 ), tetrahydrofuran (THF), toluene (PhMe), benzene (PhH), N,N-dimethylformamide (DMF), acetonitrile (CH 3 CN), triethylamine (Et 3 N), N,N-diisopropylamine and methanol (MeOH) were all degassed with argon and passed through a solvent purification system containing alumina or molecular sieves. (23) . A solution of diethyl azodicarboxylate (DEAD; 161 mg solution, 168 ml, 40% in toluene, 0.369 mmol) was added to a solution of 22 (57 mg, 0.123 mmol) in CH 2 Cl 2 (5 ml) at room temperature. The reaction was stirred for 5 min, and then PBu 3 (75 mg, 92 ml, 0.369 mmol) was added. The reaction was stirred at room temperature for 12 h, after which time the entire contents were concentrated under reduced pressure. The residue was purified by flash chromatography eluting with EtOAc/hexanes CDCl 3 ) d 11.84 (s, 1H), 8.79 (s, 1H) 
